公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2010 | Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia | SHEY-YING CHEN ; JANN-TAY WANG ; Chen, Tony Hsiu Hsi ; Lai M.-S.; WEI-CHU CHIE ; KUO-LIONG CHIEN ; PO-REN HSUEH ; Wang J.-L.; SHAN-CHWEN CHANG | Medicine | 28 | 26 | |
2017 | Implementation of a national bundle care program to reduce catheter-associated urinary tract infection in high-risk units of hospitals in Taiwan | Lai C.-C.; Lee C.-M.; Chiang H.-T.; Hung C.-T.; Chen Y.-C.; Su L.-H.; Shi Z.-Y.; Liu J.-W.; Liu C.-P.; Lu M.-C.; Chuang Y.-C.; Ko W.-C.; Tseng S.-H.; Chen Y.-H.; PO-REN HSUEH ; for the, Infection Control Society of Taiwan | Journal of Microbiology, Immunology and Infection | 13 | 10 | |
2018 | Implementation of a national bundle care program to reduce central line-associated bloodstream infections in intensive care units in Taiwan | Lai C.-C.; Cia C.-T.; Chiang H.-T.; Kung Y.-C.; Shi Z.-Y.; Chuang Y.-C.; Lee C.-M.; Ko W.-C.; PO-REN HSUEH ; for the Infection Control Society of Taiwan | Journal of Microbiology, Immunology and Infection | 15 | 13 | |
2019 | Implementation of a national quality improvement program to enhance hand hygiene in nursing homes in Taiwan | Lai C.-C.; Lu M.-C.; Tang H.-J.; Chen Y.-H.; Wu Y.-H.; Chiang H.-T.; Wu L.-H.; Ko W.-C.; PO-REN HSUEH ; Chen Y.-H.; for Infection Control Society of Taiwan | Journal of Microbiology, Immunology and Infection | 10 | 7 | |
2013 | Implementation of community influenza centers and vaccination campaign in protecting healthcare workers and control of pandemic (H1N1) 2009 in Taipei City, Taiwan | Yen M.-Y.; Lee W.-S.; Hu P.-H.; Kuo B.I.T.; LIN-CHUNG WOUNG ; Chiu A.W.H.; Liu W.-L.; PO-REN HSUEH | Journal of Infection | 2 | 2 | |
2022 | The implications of the COVID-19 pandemic for long term care facilities | Yen, Muh-Yong; Schwartz, Jonathan; PO-REN HSUEH | Current opinion in infectious diseases | 5 | 4 | |
1999 | Imported malaria: Successful treatment of 31 patients in the era of chloroquine resistance | CHI-TAI FANG ; SHAN-CHWEN CHANG ; Chang H.-L.; YEE-CHUN CHEN ; PO-REN HSUEH ; CHIEN-CHING HUNG ; Hsieh W.-C. | Journal of the Formosan Medical Association | 4 | 2 | |
2010 | In response | Lai C.-C.; Tan C.-K.; Chou C.-H.; Hsu H.-L.; Liao C.-H.; YU-TSUNG HUANG ; PAN-CHYR YANG ; KWEN-TAY LUH ; PO-REN HSUEH | Emerging Infectious Diseases | 1 | 0 | |
2006 | In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan | Liao C.-H.; WANG-HUEI SHENG ; JANN-TAY WANG ; HSIN-YUN SUN ; Wang H.-K.; PO-REN HSUEH ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 26 | 0 | |
2002 | In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia | SHWU-JEN LIAW ; LEE-JENE TENG ; PO-REN HSUEH ; Ho S.-W.; KWEN-TAY LUH | Journal of the Formosan Medical Association | 27 | 19 | |
2019 | In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan | Hsueh S.-C.; Lee Y.-J.; YU-TSUNG HUANG ; Liao C.-H.; Tsuji M.; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 82 | 73 | |
2023 | In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021 | Lee, Yu-Lin; Ko, Wen-Chien; PO-REN HSUEH | International journal of antimicrobial agents | 2 | 0 | |
2010 | In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme | Jean S.-S.; PO-REN HSUEH ; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y. | European Journal of Clinical Microbiology and Infectious Diseases | 21 | 16 | |
2009 | In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006 | Liu C.-Y.; Lu C.-L.; YU-TSUNG HUANG ; Liao C.-H.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 4 | 5 | |
2008 | In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan | Liu, Chia-Ying; YU-TSUNG HUANG ; Liao, Chun-Hsing; PO-REN HSUEH | Antimicrobial agents and chemotherapy | 21 | 17 | |
2005 | In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan | Cheng N.-C.; PO-REN HSUEH ; Liu Y.-C.; Shyr J.-M.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y. | Microbial Drug Resistance | 28 | 26 | |
2007 | In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data | Hung M.-N.; PO-REN HSUEH ; Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y.; KWEN-TAY LUH | International Journal of Antimicrobial Agents | 13 | 8 | |
2021 | In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020 | Liu, Po-Yu; Ko, Wen-Chien; Lee, Wen-Sen; Lu, Po-Liang; Chen, Yen-Hsu; Cheng, Shu-Hsing; Lu, Min-Chi; Lin, Chi-Ying; Wu, Ting-Shu; Yen, Muh-Yong; Wang, Lih-Shinn; Liu, Chang-Pan; PEI-LAN SHAO ; Lee, Yu-Lin; Shi, Zhi-Yuan; Chen, Yao-Shen; Wang, Fu-Der; Tseng, Shu-Hui; Lin, Chao-Nan; Chen, Yu-Hui; WANG-HUEI SHENG ; Lee, Chun-Ming; Tang, Hung-Jen; PO-REN HSUEH | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 17 | 10 | |
2018 | In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) | Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; PEI-LAN SHAO ; Ko W.-C.; Wang F.-D.; PO-REN HSUEH | Infection and Drug Resistance | 34 | 34 | |
2023 | In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020 | Chang, Chih-Yen; Lee, Yu-Lin; YU-TSUNG HUANG ; Ko, Wen-Chien; Ho, Mao-Wang; PO-REN HSUEH | International journal of antimicrobial agents | 0 | 0 | |